相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
F. Conforti et al.
ESMO OPEN (2021)
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naive Metastatic Breast Cancer
Richard S. Finn et al.
CLINICAL CANCER RESEARCH (2020)
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial
Jun Sato et al.
LANCET ONCOLOGY (2020)
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy
Paolo Andrea Zucali et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone et al.
LANCET ONCOLOGY (2018)
A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma
Olumide B. Gbolahan et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas
Scott W. Aesif et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthetase level
Xinyu Qian et al.
ONCOTARGETS AND THERAPY (2016)
Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7
Marlies Keijzers et al.
DIAGNOSTIC PATHOLOGY (2015)
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors
Hae Su Kim et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas et al.
LANCET ONCOLOGY (2015)
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
State of the Art of Genetic Alterations in Thymic Epithelial Tumors
Arun Rajan et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial
Arun Rajan et al.
LANCET ONCOLOGY (2014)
Thymic epithelial tumours: from basic principles to individualised treatment strategies
Nicolas Girard
EUROPEAN RESPIRATORY REVIEW (2013)
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Thymoma A Focus on Current Therapeutic Management
Nicolas Girard et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Thymic epithelial turnours: A population-based study of the incidence, diagnostic procedures and therapy
Wouter K. de Jong et al.
EUROPEAN JOURNAL OF CANCER (2008)
分享论文
